Controversy Over Testosterone Treatment

Controversy Over Testosterone Treatment

The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone therapy in healthy girls. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study involved roughly 800 older men with low testosterone and symptoms related to this condition, including http://tinyurl.com/hvm4td7 physical and sexual dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.

Research has shown that testosterone deficiency is associated with a number of significant health issues like obesity, diabetes, metabolic syndrome, and bone fractures Men who meet medical criteria for treatment should receive therapy. The truth is, your testosterone levels have probably been slowly declining for quite some time, a downfall that typically begins around age 30.

And many girls have a knee-jerk suspicion that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only does not raise a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will probably stay the status quo for a little while, given the prohibitive cost of conducting the long-term safety studies needed to win fuller FDA acceptance.